Loading…
KORU Medical Systems, Inc. is projected to rise to $5.25 by 2027, a +23% move from its current price of $4.28. KRMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean neutral.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $4.18 | $4.28 | $4.39 | +0.07% |
| Jul 13 | $4.14 | $4.29 | $4.44 | +0.14% |
| Jul 14 | $4.11 | $4.29 | $4.47 | +0.21% |
| Jul 15 | $4.09 | $4.29 | $4.51 | +0.28% |
| Jul 16 | $4.07 | $4.29 | $4.53 | +0.35% |
| Jul 17 | $4.05 | $4.30 | $4.56 | +0.42% |
| Jul 18 | $4.03 | $4.30 | $4.59 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.03 | $4.30 | $4.59 | +0.49% |
| Week 2 | $3.95 | $4.32 | $4.73 | +0.98% |
| Week 3 | $3.89 | $4.34 | $4.85 | +1.47% |
| Week 4 | $3.84 | $4.36 | $4.96 | +1.96% |
| Week 5 | $3.80 | $4.39 | $5.06 | +2.46% |
| Week 6 | $3.77 | $4.41 | $5.16 | +2.96% |
| Week 7 | $3.74 | $4.43 | $5.25 | +3.46% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.
The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing.
The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
KRMD is a healthcare company trading in the sector with a current price of $4.49. Its market capitalization stands at $206.24M and it ranks 3705 by market cap.
The price outlook is supported by a bullish technical backdrop and the stock’s forecast trajectory shows higher average prices over time, with the 30-day technical picture reinforcing the near-term bullish stance.
Forecasts indicate a rising path in average prices across multiple years, including a 2026 average around the current price level and meaningful upside into the 2030s and beyond, culminating in substantial long-run upside as reflected by higher foreseen ROIs.
A major floor 18.1% below — a decisive break under it would weaken the trend.
The nearest floor, 9.8% below — buyers have tended to step in here.
The nearest ceiling, 7.5% above — a clean break opens room to run.
A major ceiling 16.5% above — clearing it would confirm fresh momentum.
Key KRMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.47 | Sell | $4.40 | Sell |
| MA 10 | $4.42 | Sell | $4.37 | Sell |
| MA 20 | $4.21 | Buy | $4.28 | Sell |
| MA 50 | $4.11 | Buy | $4.21 | Buy |
| MA 100 | $4.26 | Buy | $4.30 | Sell |
| MA 200 | $4.59 | Sell | $4.31 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.47 | Neutral |
| Stoch RSI (14) | 37.27 | Neutral |
| CCI (20) | 19.88 | Neutral |
| Williams %R (14) | -43.24 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 3.63 | Buy |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 56.76 | Neutral |
| TRIX (15) | 0.33 | Buy |
| Awesome (5,34) | 0.31 | Buy |
| Ultimate (7,14,28) | 57.13 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 4.43 | Sell |
| ADX (14) | 15.29 | Neutral |
| ATR (14) | 0.10 | Info |
The 30-day picture is bullish, with RSI14 at 60, and a sentiment labeled BULLISH.
Nearby moving averages show SMA50 at $4.07 and SMA200 at $4.58, providing a near-term framework around the current price. Support is seen at $3.86, with resistance at $4.49, creating a trading range that fits the 30-day outlook.
The thirty-day price range runs from $3.80 to $5.31, indicating upside potential beyond the current level while keeping downside risk into a clearly defined band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.83 | $4.28 | $5.87 | 0% | Neutral | |
| $4.22 | $5.25 | $6.88 | +23% | Bullish | |
| $4.61 | $5.88 | $7.96 | +37% | Bullish | |
| $4.72 | $6.14 | $8.53 | +43% | Bullish | |
| $4.84 | $6.40 | $9.10 | +50% | Bullish | |
| $5.48 | $7.37 | $10.68 | +72% | Bullish | |
| $6.36 | $8.68 | $12.80 | +103% | Bullish | |
| $7.32 | $10.14 | $15.18 | +137% | Bullish | |
| $7.56 | $10.61 | $16.13 | +148% | Bullish | |
| $7.25 | $10.30 | $15.87 | +141% | Bullish | |
| $11.24 | $16.93 | $27.60 | +296% | Bullish | |
| $18.53 | $30.76 | $54.51 | +619% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.83 | $4.28 | $5.17 | +0.00% |
| August 2026 | $3.73 | $4.39 | $5.29 | +2.54% |
| September 2026 | $3.85 | $4.56 | $5.56 | +3.89% |
| October 2026 | $3.98 | $4.74 | $5.82 | +3.95% |
| November 2026 | $3.95 | $4.72 | $5.84 | -0.36% |
| December 2026 | $3.93 | $4.72 | $5.87 | -0.12% |
Click any year to see its month-by-month KRMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The KRMD price prediction for 2026 points to an average of $4.28 (low $3.83, high $5.87) — a potential gain of 0% on today's $4.28. A consolidation phase looks the most probable path here.
In 2027, KRMD is projected to trade between $4.22 and $6.88, averaging $5.25 — a potential gain of +23% from today's $4.28. That is up +23% on the projected 2026 average. Momentum favours further upside here.
KORU Medical Systems, Inc.'s 2028 outlook centres on $5.88, within a $4.61 to $7.96 range. That is up +12% on the projected 2027 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, KRMD could reach as high as $8.53, with a base case around $6.14 and support toward $4.72 — roughly +43% from $4.28. Momentum favours further upside here.
Expect KRMD to range from $4.84 to $9.10 through 2030. The $6.40 average target implies a +50% move from current prices. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The KRMD price prediction for 2031 points to an average of $7.37 (low $5.48, high $10.68) — a potential gain of +72% on today's $4.28. Momentum favours further upside here.
In 2032, KRMD is projected to trade between $6.36 and $12.80, averaging $8.68 — a potential gain of +103% from today's $4.28. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
KORU Medical Systems, Inc.'s 2033 outlook centres on $10.14, within a $7.32 to $15.18 range. That is up +17% on the projected 2032 average. That marks a +137% change versus current levels. Momentum favours further upside here.
By 2034, KRMD could reach as high as $16.13, with a base case around $10.61 and support toward $7.56 — roughly +148% from $4.28. Buyers look set to stay in control over this stretch.
Expect KRMD to range from $7.25 to $15.87 through 2035. The $10.30 average target implies a +141% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The KRMD price prediction for 2040 points to an average of $16.93 (low $11.24, high $27.60) — a potential gain of +296% on today's $4.28. Buyers look set to stay in control over this stretch.
In 2050, KRMD is projected to trade between $18.53 and $54.51, averaging $30.76 — a potential gain of +619% from today's $4.28. That is up +82% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in KRMD today (≈ 233.64486 KRMD) could be worth
$7,187.73
+$6,187.73 (+619%) by 2050 · US Dollar
Based on the average projected KRMD price of $30.76 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRMDwould be worth at today's price.
$1,000 invested in KRMD on Jul 10, 2025 (≈ 268.096513 KRMD) would be worth
$1,147.45
+$147.45 (+14.7%) today · 1.15× · US Dollar
Based on a KRMD entry price of $3.73 vs. today's $4.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.49 | $953.23 | -4.7% |
| 1 month ago | $3.98 | $1,075.38 | +7.5% |
| 3 months ago | $4.21 | $1,016.63 | +1.7% |
| 6 months ago | $5.89 | $726.66 | -27.3% |
| 1 year ago | $3.73 | $1,147.45 | +14.7% |
| All time (5.0y) ago | $3.64 | $1,175.82 | +17.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRMD forecast.
Our base-case forecast reaches $8.60 around 2032.
Implied market cap at $8.60: $395.02M
Over the multi-year forecast horizon, KRMD shows a rising average price and compelling upside. The 2026 forecast lists an avg of $4.49 with a neutral sentiment.
By 2030, the avg is $6.93 with a ROI of 54.2% and bullish sentiment, followed by 2031 with an avg of $8.04 and ROI 79%. The path continues higher through 2032 (avg $9.71, ROI 116.2%), 2033 (avg $11.24, ROI 150.4%), 2034 (avg $11.69, ROI 160.4%), and 2035 (avg $11.52, ROI 156.5%).
Farther out, 2040 shows an avg of $19.12 with ROI 325.9% and bullish sentiment, and 2050 shows an avg of $35.78 with ROI 696.9% and bullish sentiment.
Tap a question to reveal the answer.
The forecast for 2030 lists min $5.20, avg $6.93, max $9.93; ROI 54.2%; sentiment bullish.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs (e.g., 2027 avg $5.60, ROI 24.8%; 2028 avg $6.24, ROI 39.1%; 2029 avg $6.63, ROI 47.7%; 2030 avg $6.93, ROI 54.2%). These are estimates, not guarantees.
Yes. The 2050 forecast max is $64.37, with a min of $21.12 and an avg of $35.78, yielding a ROI of 696.9% and bullish sentiment.
Current price is $4.49 and market cap is $206.24M, with a market ranking of 3705.
Sentiment is BULLISH; RSI14 is 60. SMA50 is $4.07; SMA200 is $4.58; support is $3.86 and resistance is $4.49. The thirty-day range is $3.80 to $5.31, and annualized volatility is 50%.
KORU Medical Systems, Inc. Community Discussion
0Share your KORU Medical Systems, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.